Literature DB >> 27965384

Signal transducer and activator of transcription 3 (Stat3) regulates host defense and protects mice against herpes simplex virus-1 (HSV-1) infection.

Hung-Ching Hsia1,2, Charles M Stopford2, Zhigang Zhang2, Blossom Damania2,3, Albert S Baldwin4,2.   

Abstract

Signal transducer and activator of transcription 3 (STAT3) mediates cellular responses to multiple cytokines, governs gene expression, and regulates the development and activation of immune cells. STAT3 also modulates reactivation of latent herpes simplex virus-1 (HSV-1) in ganglia. However, it is unclear how STAT3 regulates the innate immune response during the early phase of HSV-1 lytic infection. Many cell types critical for the innate immunity are derived from the myeloid lineage. Therefore, in this study, we used myeloid-specific Stat3 knockout mice to investigate the role of STAT3 in the innate immune response against HSV-1. Our results demonstrate that Stat3 knockout bone marrow-derived macrophages (BMMs) expressed decreased levels of interferon-α (IFN-α) and interferon-stimulated genes (ISGs) upon HSV-1 infection. In vivo, knockout mice were more susceptible to HSV-1, as marked by higher viral loads and more significant weight loss. Splenic expression of IFN-α and ISGs was reduced in the absence of STAT3, indicating that STAT3 is required for optimal type I interferon response to HSV-1. Expression of TNF-α and IL-12, cytokines that have been shown to limit HSV-1 replication and pathogenesis, was also significantly lower in knockout mice. Interestingly, Stat3 knockout mice failed to expand the CD8+ conventional DC (cDC) population upon HSV-1 infection, and this was accompanied by impaired NK and CD8 T cell activation. Collectively, our data demonstrate that myeloid-specific Stat3 deletion causes defects in multiple aspects of the immune system and that STAT3 has a protective role at the early stage of systemic HSV-1 infection. © Society for Leukocyte Biology.

Entities:  

Keywords:  dendritic cells; innate immunity; natural killer cells; type I interferons; viral infection

Mesh:

Substances:

Year:  2016        PMID: 27965384      PMCID: PMC5346178          DOI: 10.1189/jlb.4A1016-199RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  68 in total

1.  Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus.

Authors:  J R Lokensgard; S Hu; W Sheng; M vanOijen; D Cox; M C Cheeran; P K Peterson
Journal:  J Neurovirol       Date:  2001-06       Impact factor: 2.643

2.  Hematopoietic stem cells expressing the myeloid lysozyme gene retain long-term, multilineage repopulation potential.

Authors:  Min Ye; Hiromi Iwasaki; Catherine V Laiosa; Matthias Stadtfeld; Huafeng Xie; Susanne Heck; Bjorn Clausen; Koichi Akashi; Thomas Graf
Journal:  Immunity       Date:  2003-11       Impact factor: 31.745

3.  Selective effects of anti-macrophage serum, silica and anti-lymphocyte serum on pathogenesis of herpes virus infection of young adult mice.

Authors:  B Zisman; M S Hirsch; A C Allison
Journal:  J Immunol       Date:  1970-05       Impact factor: 5.422

4.  Molecular localization of abortive infection of resident peritoneal macrophages by herpes simplex virus type 1.

Authors:  P S Morahan; S Mama; F Anaraki; K Leary
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

5.  Role of MIP-2 in neutrophil migration and tissue injury in the herpes simplex virus-1-infected cornea.

Authors:  X T Yan; T M Tumpey; S L Kunkel; J E Oakes; R N Lausch
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-09       Impact factor: 4.799

Review 6.  Regulation of type I interferon responses.

Authors:  Lionel B Ivashkiv; Laura T Donlin
Journal:  Nat Rev Immunol       Date:  2014-01       Impact factor: 53.106

7.  Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication.

Authors:  K D Croen
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

8.  Aberrant inflammation and lethality to septic peritonitis in mice lacking STAT3 in macrophages and neutrophils.

Authors:  Akihiro Matsukawa; Kiyoshi Takeda; Shinji Kudo; Takako Maeda; Motoko Kagayama; Shizuo Akira
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

9.  STAT3 restrains RANK- and TLR4-mediated signalling by suppressing expression of the E2 ubiquitin-conjugating enzyme Ubc13.

Authors:  Huiyuan Zhang; Hongbo Hu; Nathaniel Greeley; Jin Jin; Allison J Matthews; Erika Ohashi; Mauricio S Caetano; Haiyan S Li; Xuefeng Wu; Pijus K Mandal; John S McMurray; Seyed Javad Moghaddam; Shao-Cong Sun; Stephanie S Watowich
Journal:  Nat Commun       Date:  2014-12-15       Impact factor: 14.919

10.  Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs.

Authors:  Hiroyuki Yoneyama; Kenjiro Matsuno; Etsuko Toda; Tetsu Nishiwaki; Naoki Matsuo; Akiko Nakano; Shosaku Narumi; Bao Lu; Craig Gerard; Sho Ishikawa; Kouji Matsushima
Journal:  J Exp Med       Date:  2005-08-01       Impact factor: 14.307

View more
  5 in total

1.  Activation of JAK/STAT3 restores NK-cell function and improves immune defense after brain ischemia.

Authors:  Wei-Na Jin; Andrew F Ducruet; Qiang Liu; Samuel Xiang-Yu Shi; Michael Waters; Ming Zou; Kevin N Sheth; Rayna Gonzales; Fu-Dong Shi
Journal:  FASEB J       Date:  2018-01-08       Impact factor: 5.191

2.  JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors.

Authors:  Emily A Irey; Chelsea M Lassiter; Nicholas J Brady; Pavlina Chuntova; Ying Wang; Todd P Knutson; Christine Henzler; Thomas S Chaffee; Rachel I Vogel; Andrew C Nelson; Michael A Farrar; Kathryn L Schwertfeger
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-30       Impact factor: 11.205

Review 3.  The Dynamic Interface of Viruses with STATs.

Authors:  Angela R Harrison; Gregory W Moseley
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

4.  C1Q/TNF-related protein 4 expression correlates with herpes simplex encephalitis progression.

Authors:  Wangshu Xu; Heng Zhou; Xiaojuan Li; Lu Wang; Xinwu Guo; Linlin Yin; Haoxiao Chang; Yuzhen Wei; Qingsong Li; Jinhai Deng; Xingang Zhou; Haifeng Yang; Xinghu Zhang; Fang Yi; Wenping Ma
Journal:  Ann Transl Med       Date:  2019-06

Review 5.  Interplay between Janus Kinase/Signal Transducer and Activator of Transcription Signaling Activated by Type I Interferons and Viral Antagonism.

Authors:  Yuchen Nan; Chunyan Wu; Yan-Jin Zhang
Journal:  Front Immunol       Date:  2017-12-11       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.